We serve Chemical Name:3,6-dimethyl-5-nitropyridin-2-ol CAS:57179-69-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3,6-dimethyl-5-nitropyridin-2-ol
CAS.NO:57179-69-8
Synonyms:6-Hydroxy-3-nitro-2,5-lutidin;3,6-Dimethyl-5-nitropyridin-2-ol
Molecular Formula:C7H8N2O3
Molecular Weight:168.150
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:395.2±42.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.591
PSA:78.94000
Exact Mass:168.053497
LogP:0.47
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 6-Hydroxy-3-nitro-2,5-lutidin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,6-Dimethyl-5-nitropyridin-2-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,6-Dimethyl-5-nitropyridin-2-ol Use and application,3,6-Dimethyl-5-nitropyridin-2-ol technical grade,usp/ep/jp grade.
Related News: During an investor event last month, Walmsley laid out her blueprint for the new GSK. It features a 5% average sales growth rate in the next five years, leading to total sales of £33 billion ($46 billion) by 2031. O-Aethyl-N-butyl-N-chloracetyl-carbamat manufacturers The green light converts the companies’ accelerated approval to a full approval for endometrial cancer that’s not microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) and for patients whose tumors have progressed following prior treatment. (3R,4S,5S)-3,4-Bis-(tert-butyl-dimethyl-silanyloxy)-5-[(S)-2-(tert-butyl-dimethyl-silanyloxy)-1-hydroxy-ethyl]-dihydro-furan-2-one suppliers These companies need cost-effective, seamless ways to move small molecule compounds from early-phase to commercial according to global quality and regulatory standards, and these expanded facilities at our Nansha site are designed to help them to do so.” 3H,6H,8bH-2a,5a,8a-Triazaacenaphthylene, hexahydro- vendor & factory Bluebird also earned an approval Wednesday in Europe for its gene therapy Lenti-D for children with early cerebral adrenoleukodystrophy and an ABCD1 genetic mutation without a matched sibling donor.,These companies need cost-effective, seamless ways to move small molecule compounds from early-phase to commercial according to global quality and regulatory standards, and these expanded facilities at our Nansha site are designed to help them to do so.”
